21OAssessment of cardiac outcomes in delandistrogene moxeparvovec clinical trials for Duchenne muscular dystrophy.
Saved in:
| Title: | 21OAssessment of cardiac outcomes in delandistrogene moxeparvovec clinical trials for Duchenne muscular dystrophy. |
|---|---|
| Authors: | Veerapandiyan, A.1 (AUTHOR), Bourke, J.2 (AUTHOR), Day, J.3 (AUTHOR), McDonald, C.4 (AUTHOR), Mendell, J.5 (AUTHOR), Soslow, J.6 (AUTHOR), Zaidman, C.7 (AUTHOR), Mason, S.5 (AUTHOR), Meng, J.5 (AUTHOR), Vivien, M.5 (AUTHOR), East, L.5 (AUTHOR), Murphy, A.8 (AUTHOR), Wandel, C.9 (AUTHOR), Richardson, J.5 (AUTHOR) |
| Source: | Neuromuscular Disorders. 2025 Supplement, Vol. 53, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09608966 |
|---|---|
| DOI: | 10.1016/j.nmd.2025.106187 |
